Siemens Healthineers AG
XETRA:SHL
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.93
57.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Siemens Healthineers AG
Siemens Healthineers AG
Income from Continuing Operations
Siemens Healthineers AG
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Siemens Healthineers AG
XETRA:SHL
|
Income from Continuing Operations
€1.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Carl Zeiss Meditec AG
XETRA:AFX
|
Income from Continuing Operations
€203.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Stratec SE
XETRA:SBS
|
Income from Continuing Operations
€10m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
|
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
|
Income from Continuing Operations
€60.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Draegerwerk AG & Co KGaA
XETRA:DRW8
|
Income from Continuing Operations
€114.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
14%
|
CAGR 10-Years
1%
|
|
|
Sartorius AG
XETRA:SRT
|
Income from Continuing Operations
€134.9m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
8%
|
|
Siemens Healthineers AG
Glance View
Siemens Healthineers AG stands at the forefront of medical technology, championing innovation in healthcare that dramatically enhances patient outcomes around the globe. Established as a subsidiary of the industrial giant Siemens AG, the company has carved out its own identity as a leader in diagnostic imaging, laboratory diagnostics, and digital health services. With a rich history spanning over a century, Siemens Healthineers has continuously evolved, investing heavily in research and development to produce cutting-edge technologies such as advanced imaging equipment like MRI and CT scanners. This relentless pursuit of excellence equips healthcare providers with the tools necessary to deliver accurate diagnoses and efficient patient care, positioning the company as a crucial player in an ever-growing healthcare market. For investors, Siemens Healthineers presents an enticing opportunity, driven by the increasing global demand for medical advancements and the aging population seeking better healthcare solutions. By capitalizing on trends like digitalization and personalized medicine, the company is poised for sustainable growth, offering a robust portfolio of products and services that cater to a diverse range of medical needs. With a strong commitment to expanding its market presence through strategic partnerships and acquisitions, Siemens Healthineers is not just a provider of medical technology; it’s a pivotal force in reshaping the future landscape of healthcare, making it an attractive investment for those looking to support innovation while reaping financial rewards.
See Also
What is Siemens Healthineers AG's Income from Continuing Operations?
Income from Continuing Operations
1.9B
EUR
Based on the financial report for Jun 30, 2024, Siemens Healthineers AG's Income from Continuing Operations amounts to 1.9B EUR.
What is Siemens Healthineers AG's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
5%
Over the last year, the Income from Continuing Operations growth was 16%. The average annual Income from Continuing Operations growth rates for Siemens Healthineers AG have been 3% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
